VIDEO: Vaccines boosted survival among STEMI heart attack patients with COVID-19
Santiago Garcia, MD, lead author of the study and director of the structural heart program at The Christ Hospital in Cincinnati, Ohio, presented new data from the North American COVID-19 STEMI (NACMI) registry at the American College of Cardiology (ACC) 2022 meeting. He reported a 25% reduction in early mortality in 2021 compared to 2020 among patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19 infection and zero deaths for patients vaccinated against SARS-CoV-2. The data was presented as a late-breaking study.
The NACMI registry is a collaboration between Society for Cardiovascular Angiography and Interventions (SCAI), ACC and Canadian Association of Interventional Cardiology (CAIC). The registry was established in 2020 with to define baseline characteristics and management strategies and outcome data for COVID-positive patients presenting with STEMI. Sixty-four medical centers across North America and Canada contributed data to the registry. In the initial findings, it was reported that 33% of North American patients with both COVID-19 and a STEMI heart attack died in the hospital.
"We have seen significant changes in the patient profiles," Garcia said. "In the first wave of patients we treated in 2020, there was a preponderance of ethnic minorities of about 50%, which is rare for a North American STEMI registry. In 2021, the face of the STEMI patient was different with the majority being Caucasians who are less likely to present with respiratory symptoms and were more likely to present with the usual ischemic symptoms."
He said this change was not arbitrary, it was caused by increasing numbers of people getting the COVID vaccine.
Read more in the article — How the availability of vaccines impacted outcomes among STEMI patients with COVID-19
Links to all the ACC 2022 late-breaking clinical trials
Key Interventional Cardiology Takeaways at ACC 2022
Related COVID-19 Cardiology Content:
ACC consensus explains what cardiologists should look for in long COVID-19
COVID-19 vaccines safe for patients with a history of heart damage
Athletes with COVID-19 may require heart MRI screening for myocarditis, new data suggest
4 cardiac arrhythmias associated with COVID-19
What we know about COVID-19 and cardiogenic shock
Mild COVID-19 infections not associated with long-term risk of heart damage
The pandemic’s toll: 55 long-term side effects of COVID-19
4 key takeaways from an updated look at vaccine-related myocarditis in the U.S.
Most young people with vaccine-related myocarditis recover quickly
Intrathoracic complications in COVID patients: Incidence, associations and outcomes
Congenital heart disease increases risk of poor COVID-19 outcomes, including death
MRI scans show COVID's 'significant' impact on the brain
Heart complication seen for the first time in a young patient after COVID-19 vaccination
American Heart Association investing $10 million to study the long-term consequences of COVID-19
Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com